CHD
66
2
MET
53
2
ZTS
25
5
IR
79
7
PM
66
23
RRC
76
3
KSS
37
4
NTRS
32
2
CAT
72
3
MSFT
60
3
MDT
57
-3
ADBE
50
3
KR
65
-6
CLX
53
-2
HP
49
5
SWKS
50
4
MUR
52
2
AMGN
47
6
UPS
50
4
MCHP
54
4
CHD
66
2
MET
53
2
ZTS
25
5
IR
79
7
PM
66
23
RRC
76
3
KSS
37
4
NTRS
32
2
CAT
72
3
MSFT
60
3
MDT
57
-3
ADBE
50
3
KR
65
-6
CLX
53
-2
HP
49
5
SWKS
50
4
MUR
52
2
AMGN
47
6
UPS
50
4
MCHP
54
4
Financhill
Back

Greek Organisation of Football Prognostics SA Vs. Akero Therapeutics Industry Stock Comparison

Buy
59

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:
8.83
Seasonality Move:
-4.39%
Sell
28

AKRO
Akero Therapeutics

Last Price:
21.01
Seasonality Move:
16.15%
Buy
59
Greek Organisation of Football Prognostics SA (GOFPY) is a Buy

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

  • The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $8.83. The Score for GOFPY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $21.00. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

  • The Greek Organisation of Football Prognostics SA share price today is $8.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing slight buying pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $21.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

GOFPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 51.04 Buy
Chaikin Money Flow: 1181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.6 - 9.02) Buy
Bollinger Bands (100): (8.29 - 9.11) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.18 Sell
Relative Strength Index (14 RSI): 35.31 Sell
Chaikin Money Flow: 33831 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.5 - 24.76) Sell
Bollinger Bands (100): (19.91 - 26.11) Sell

GOFPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.61 Buy
20-day SMA: 8.75 Buy
50-day SMA: 8.93 Sell
200-day SMA: 8.53 Buy
8-day EMA: 8.68 Buy
20-day EMA: 8.75 Buy
50-day EMA: 8.82 Buy
200-day EMA: 8.52 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.3 Sell
20-day SMA: 22.6 Sell
50-day SMA: 24.68 Sell
200-day SMA: 29.2 Sell
8-day EMA: 21.33 Sell
20-day EMA: 22.52 Sell
50-day EMA: 23.52 Sell
200-day EMA: 27.68 Sell

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):